- Home
- FND vs ROIV Comparison
FND vs ROIV Comparison
Compare FND & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FND | ROIV |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 25.1B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FND | ROIV |
|---|---|---|
| Price | $47.56 | $41.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $73.44 | $28.94 |
| AVG Volume (30 Days) | 2.1M | ★ 7.9M |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.05 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $4,684,088,000.00 | $8,260,000.00 |
| Revenue This Year | $7.53 | N/A |
| Revenue Next Year | $7.68 | $744.61 |
| P/E Ratio | $38.06 | ★ N/A |
| Revenue Growth | ★ 5.12 | N/A |
| 52 Week Low | $42.64 | $13.83 |
| 52 Week High | $92.41 | $42.50 |
Technical Indicators
Market Signals| Indicator | FND | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 31.92 | 66.10 |
| Support Level | $46.29 | $33.15 |
| Resistance Level | $53.19 | N/A |
| Average True Range (ATR) | 1.75 | 1.37 |
| MACD | -0.65 | 0.53 |
| Stochastic Oscillator | 7.54 | 78.11 |
Price Performance
Historical ComparisonAbout FND Floor & Decor Holdings Inc.
Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.